Navigation Links
FDA Fails to Protect Public: Remains Silent About Lead in Lipstick
Date:2/9/2009

Canada finds lead in kids' face paint, declares cosmetic chemicals toxic

WASHINGTON, Feb. 9 /PRNewswire-USNewswire/ -- More than a year after the Campaign for Safe Cosmetics reported that popular brands of lipstick contain lead, the U.S. Food and Drug Administration has still not released the results of its own testing of lead in lipstick, despite pressure from senators and repeated calls from health groups.

New reports indicate that the beauty industry's lead problems go further than lipstick. The Canadian government announced last week it found lead in children's face paint. The results were publicly announced immediately as the government evaluates next steps.

Health Canada also announced last week that it has designated two silicon-based chemicals widely used in personal care products -- D4 and D5 -- as toxic, an important step toward regulating dangerous substances out of consumer products.

Unlike Health Canada, the U.S. FDA has no such toxic designation, does not conduct routine safety testing of personal care products, and does not publicly report information in a timely manner -- as evidenced by the lead-in-lipstick situation.

In Oct. 2007, the Campaign for Safe Cosmetics reported that 61% of lipsticks it tested contained lead. In Nov. 2007, Sens. John Kerry, Barbara Boxer and Dianne Feinstein urged FDA to test a range of lipsticks for lead, publicly report the results, and take immediate action to reduce consumers' exposure to lead from cosmetic products.

Fourteen months later, FDA has made no public statements, issued no reports, and taken no action to reduce consumers' exposure.

"The typical turnaround time in a laboratory for lead tests is 10 days. There's no reason for FDA to sit on its lead-in-lipstick research for over a year," said Stacy Malkan of the Campaign for Safe Cosmetics, a national coalition of health and environmental groups.

"FDA appears to still be operating under Bush-era tactics of secrecy and delay. It's time for new leadership and new direction at FDA, so the agency can do what Americans expect it do to: ensure the safety of cosmetic products.

"The scientific data is conclusive: Lead in any amount is a health concern. Lead is a proven neurotoxin that can cause learning and behavioral problems, and pregnant women and children are particularly vulnerable."

Links: Letter from FDA; the Science of Lead in Lipstick.


'/>"/>
SOURCE Campaign for Safe Cosmetics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Imaging of Low Back Pain Fails to Change Outcomes
2. Virginia Leaders Should Reject Flawed Smoke-Free Legislation That Fails to Protect Everyones Right to Breathe Clean Air
3. HIPAA privacy rule fails to adequately protect patient privacy and hampers health research
4. Sepsis Therapy in Preemies Fails to Boost Survival
5. Common treatment for chronic prostatitis fails to reduce symptoms
6. Study finds treatment fails to improve common form of heart failure
7. Nine Year Ban Fails to Eradicate Asbestos Related Diseases
8. Exercise Testing for Cancer Fails to Follow Guidelines
9. Vytorin Fails to Lower Heart Valve Problems
10. New Research Shows Cadaver Tissue Fails Nearly a Quarter of the Time in Young, Athletic ACL Reconstruction Patients
11. New Research Shows Cadaver Tissue Fails Nearly a Quarter of the Time in Young, Athletic ACL Reconstruction Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients ... can now take advantage of a cosmetic procedure known as Carbon Dioxide ... reduces the appearance of age spots, fine lines, uneven coloration, wrinkles, scarring, ...
(Date:12/2/2016)... ... , ... Lori G. Cohen and Sara K. Thompson , ... American Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place ... conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation ...
(Date:12/2/2016)... AL (PRWEB) , ... December 02, 2016 , ... ... from across the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF ... Schmitz, will help provide scholarship funds for area students and operating support to ...
(Date:12/2/2016)... ... ... The annual time frame to change Medicare health and prescription drug coverage, known ... Medicare beneficiaries who are looking to switch from their current plan to a Medicare ... during this period order for their new policy to go into effect in 2017. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... , December 2, 2016 ... Awards Committee honored excellence in research, development and innovation ... The gala dinner was held in the presence of ... the Russian Federation , Natalia Sanina, ... Mikhail Murashko , Head of Roszdravnadzor, National Service ...
(Date:12/2/2016)... RICHMOND, British Columbia , December 2, 2016 ... Produkt, den INSTI HIV-Selbsttest, bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology: